Stocks Health care GRAL
NASDAQ · Health careGRAIL, Inc. (GRAL)
GRAIL, Inc. brought in $166.6M of revenue over the twelve months to September 30, 2026, up 17.5% from a year earlier. It posted a net loss of $406.2M. In fiscal 2025 capital spending exceeded operating cash flow by $299.9M. At September 30, 2026 it held $29M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about GRAIL, Inc.
- Net worth
- GRAIL, Inc. has a market value (market cap) of $5.7B at the latest share price, and shareholders' equity of $2.5B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $147.2M (+17.2% year on year), with a net loss of $408.4M. Over the 12 months to September 30, 2026: revenue $166.6M, net loss $406.2M.
- Cash flow
- In fiscal 2025 operations used $299M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- GRAIL, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What GRAIL, Inc. does
GRAIL, Inc. is registered with the SEC under industry code SIC 8071 (Services-Medical Laboratories). Its shares trade on NASDAQ under the ticker GRAL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $147.2M | -$408.4M | -$11.11 | -$299.9M |
| 2024 | $125.6M | -$2B | -$63.54 | -$582.4M |
| 2024 | $93.1M | -$1.5B | -$47.21 | -$608.7M |
| 2022 | $55.6M | -$5.4B | -$173.89 | -$584.2M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where GRAL ranks in Health care
Latest SEC filings
What GRAIL, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 3.7% to $37.5M versus the same quarter last year; diluted EPS -$2.21 versus -$2.46.
- November 5, 2026Passive stake changed SCHEDULE 13G/A
- November 4, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- August 7, 2026Passive stake (5% or more) SCHEDULE 13G
- August 6, 2026Passive stake changed SCHEDULE 13G/A
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 26% to $44.7M versus the same quarter last year; diluted EPS -$2.56 versus -$3.18.
- August 5, 2026
- July 28, 2026Passive stake changed SCHEDULE 13G/A
- June 22, 2026
Insider trades
What the people running GRAIL, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $14.8M worth of shares in the last 90 days and bought none on the open market. Most of the selling (69%) was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 15, 2026 | Mizell StevenDirector | Received as pay | 148 | $20K |
| October 15, 2026 | Ofman Joshua J.Chief Executive Officer, Director | Soldpre-planned (10b5-1) | 400 | $53.2K |
| October 15, 2026 | Ofman Joshua J.Chief Executive Officer, Director | Soldpre-planned (10b5-1) | 1,000 | $134.4K |
| October 15, 2026 | Ofman Joshua J.Chief Executive Officer, Director | Soldpre-planned (10b5-1) | 3,400 | $460.5K |
| October 15, 2026 | Ofman Joshua J.Chief Executive Officer, Director | Soldpre-planned (10b5-1) | 7,052 | $964.9K |
| October 15, 2026 | Ofman Joshua J.Chief Executive Officer, Director | Soldpre-planned (10b5-1) | 6,034 | $830.5K |
| October 15, 2026 | Ofman Joshua J.Chief Executive Officer, Director | Soldpre-planned (10b5-1) | 2,114 | $293.4K |
| October 15, 2026 | Chase William JDirector | Received as pay | 153 | $20.7K |
Who owns GRAL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Baker Bros. Advisors LP13G, passive with 3 related filers | 9.8% | May 15, 2026 |
| Farallon Capital Management, L.L.C.13G, passive with 28 related filers | 9.6% | August 13, 2026 |
| Dapice Joshua J.13G, passive with 27 related filers | 7.8% | May 11, 2026 |
| Primecap Management Co13G, passive | 5.08% | August 6, 2026 |
| Crcm LP13G, passive with 8 related filers | 5% | October 6, 2025 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 373 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Farallon Capital Management, L.L.C. | 4,161,584 | +907,900 |
| Baker Bros. Advisors LP | 4,028,614 | 0 |
| BlackRock, Inc. | 3,577,075 | +608,539 |
| State Street Corp | 2,385,514 | +493,621 |
| Primecap Management Co | 2,180,106 | +336,334 |
| Arbiter Partners Capital Management LLC | 2,068,594 | +1,033,997 |
| Sessa Capital IM, L.P. | 2,037,518 | +318,204 |
| Deep Track Capital, LP | 1,834,944 | +112,147 |
| Vanguard Capital Management LLC | 1,641,117 | +114,012 |
| Morgan Stanley | 1,462,163 | -170,032 |
| Geode Capital Management, LLC | 991,380 | +163,438 |
| Goldman Sachs Group Inc | 748,015 | +166,091 |
| Jefferies Financial Group Inc. | 724,000 | +66,500 |
| Bank of America Corp | 723,437 | -190,677 |
| Dimensional Fund Advisors LP | 679,587 | +270,937 |
| Casdin Capital, LLC | 480,000 | +250,000 |
| Vanguard Portfolio Management LLC | 477,982 | +143,076 |
| Northern Trust Corp | 372,588 | +23,451 |
| Citigroup Inc | 371,253 | +69,117 |
| Kingdon Capital Management, L.L.C. | 340,000 | new |
Insiders
8 insiders reported holding 1,416,728 shares in total, about $181.5M at the last price.
| Holder | Shares |
|---|---|
| Ragusa Robert PChief Executive Officer, Director | 518,582 |
| Ofman Joshua J.Chief Executive Officer, Director | 342,271 |
| Freidin AaronChief Financial Officer | 225,364 |
| Partridge Andrew JohnChief Growth Officer | 155,865 |
| Summe Gregory LDirector | 45,909 |
| Chase William JDirector | 43,131 |
| Mizell StevenDirector | 42,978 |
| Krevans SarahDirector | 42,628 |
Questions about GRAL
What does GRAIL, Inc. do?
GRAIL, Inc. is a company in the Health care sector, listed on NASDAQ as GRAL. Its shares trade on NASDAQ under the ticker GRAL.
What is GRAIL, Inc.'s net worth?
GRAIL, Inc. has a market value (market cap) of $5.7B at the latest share price, and shareholders' equity of $2.5B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is GRAIL, Inc. profitable?
No. Over the twelve months to September 30, 2026 it reported a net loss of $406.2M on revenue of $166.6M.
How much revenue does GRAIL, Inc. make?
Over the twelve months to September 30, 2026 GRAIL, Inc. reported revenue of $166.6M. That is 17.5% more than a year earlier.
When did GRAIL, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.
When is GRAIL, Inc.'s next earnings report?
GRAIL, Inc.'s next report is expected around January 11, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare GRAL with
Follow GRAL
Get an email when GRAIL, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values GRAIL, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.